SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2227It was not me doing that trade, as my holdings are at least an order of magnitudBiotech Jim-8/5/2008
2226Somebody decided to dump around 600k shares in one swoop about half an hour ago tom pope-8/5/2008
2225thanks, BJ. i look forward to hearing the rest of your comments. salessoftware salesperson-8/1/2008
2224Interesting discussion on INCY and myelofibrosis etc, and I will chime in here. Biotech Jim-7/31/2008
2223rkrw, 1) This controversy was started in early June. I have cut and pasted the software salesperson-7/31/2008
2222At least a couple of analysts out there are saying it's a murky path for 424rkrw-7/31/2008
2221Thanks again - particularly for your impressions.nigel bates-7/31/2008
22207/30/08 cc highlights 1. opening remarks (i) 18424 MF continuing enrollment software salesperson-7/31/2008
22196/10 GS conference MF is characterized by bone marrow failure 18424 is diseasesoftware salesperson-6/18/2008
2218Incyte's JAK Inhibitor Demonstrates Marked Clinical Benefits in Phase IIa Rhkenhott-6/12/2008
2217Abstract No 7004 INCB 14724 as released by ASCO tonight: " Abstract No: 70quantman-5/15/2008
2216Unless INCY has tied up JAK1,2,3 and TYK2, it is not at all clear to me what thetommysdad-5/6/2008
2215In the Incyte genomics days, it seemed that Incyte's IP strategy of patentintuck-5/5/2008
2214Thanks, Tuck. Appreciate your thoughts and suggestions on the IP side of thingsquantman-5/5/2008
2213Hi, Quantman, and let me also extend a biofreak welcome . . . >>I tuck-5/3/2008
2212Thanks, Sales. I value your thoughts very much, and so thanks for your feedback.quantman-5/3/2008
2211quantman, welcome to SI. 1. <I> Friedman throttled back some on MF, and software salesperson-5/1/2008
2210Sales- Thanks again for the nice summary, I will have to listen to the presentaBiotech Jim-4/30/2008
2209Thanks, Sales for an as-usual excellent summary. I too listened and thought CEOquantman-4/30/2008
22084/30/08 cc highlights: 1. opening remarks (i) 18424 - - continuing to add patsoftware salesperson-4/30/2008
2207Sorry, my info on Renaissance Tech holdings was incorrect - they are NOT a new pquantman-4/29/2008
2206Thoughts from a newbie to INCY - Got on my radar due to Renaissance Technologiequantman-4/29/2008
2205"i am as confident as i have ever been about anything in science or medicinkenhott-3/18/2008
2204re: endpoint(s) for registration studies of lead JAK inhibitor for MF after discsoftware salesperson-3/17/2008
2203Thanks from me too. I listened. These guys are cooking.kenhott-2/15/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News